From: Factors Confounding the Athlete Biological Passport: A Systematic Narrative Review
Authors | Subjects | Interventions | [Hb] | Ret% | OFFs | Hct | PV |
---|---|---|---|---|---|---|---|
Living high-training high (LHTH) protocols | |||||||
Bonne et al. [58] | Swimmers (n = 20) | One group of swimmers lived high and trained high (LHTH, n = 10) for three to four weeks at 2130 m or higher, while a control group (n = 10) completed a three-week training camp at sea level. Haematological parameters were determined weekly three times before and four times after the training camps (+ 7, + 14, + 21 and + 28 d) | = (NS) | ↓ − 34% (7 d) | ↑ + 22% (7 d) | ↑ + 5% (7 d) | – |
Garvican et al. [59] | Cyclists (n = 13) | Haematological parameters were measured in 13 elite cyclists during and 10 d after 3 weeks of sea level or altitude training (2760 m). The altitude group participated in a 3-week natural altitude training camp at Passo dello Stelvio, Italy, living at 2760 m and training during the majority of ride time > 1800 m for 2–6 h d−1 | = (NS) | ↑ + 25% | – | = (NS) | – |
↑ (12 d) | |||||||
↓ (31 d) | |||||||
Wachsmuth et al. [60] | Swimmers (n = 27) | Twenty-five athletes trained between one and three times for 3–4 weeks at altitude training camps. Three training camp were at 2320 m (G1) in Sierra Nevada, Spain, and one training camp was at 1360 m (G2) in Pretoria, South Africa | = ↑ + 4% (4 weeks) | =/= (NS) | =/= (NS) | =/= (NS) | =/= (NS) |
Ashenden et al. [61] | Endurance athletes (n = 23) | The haematological and physiological responses of 23 well-trained athletes (12 cyclists, 10 kayakers, 13 triathletes and 11 middle-distance runners) exposed to a simulated altitude of 2650 m for 11 ± 23 nights (ALT) were contrasted with those of healthy volunteers receiving a low dose (150 IU·kg−1 per week) of rEPO for 25 d (DOP) | – | ↑ + 36% (17 d) | – | – | – |
Living high-training low (LHTL) protocols | |||||||
Ashenden et al. [62] | Endurance athletes (n = 64) | Haematologic data were collected from three groups: 19 elite cyclists who lived and trained 2690 m above sea level for 26–31 d (LH-TH), from 39 well-trained subjects who resided at sea level but slept at a simulated altitude of 2650–3000 m for 20–23 d of consecutive or intermittent nightly exposure (LH-TL), and from six elite Kenyan runners who lived 2100 m above sea level but descended to compete at sea level competitions | ↑ (21 d) | ↑ (21 d) | ↑ (21 d) | – | – |
Garvican-Lewis et al. [63] | Endurance athletes (n = 34) | Thirty‐four endurance‐trained athletes (20 runners, 11 cyclists and three triathletes) completed 3 weeks of simulated LH-TL altitude training, accumulating an average of 14 h d−1 at a simulated altitude (normobaric hypoxia) of 3000 m. Athletes received either oral (ORAL), intravenous (IV) or placebo iron supplementation (PLA) | ↑ + 0.9 | ↓ − 0.2% | ↑ + 10 pt | – | – |
↑ + 0.8 | ↓ − 0.2% = (21 d) | ↑ + 8 pt | |||||
↑ + 0.6 g·dL−1 (21 d) | ↑ + 9 pt (21 d) | ||||||
Neya et al. [64] | Recreational athletes (n = 14) | Fourteen male collegiate runners were equally divided into two groups: altitude (ALT) and control (CON). Both groups spent 22 d at 1300–1800 m. The ALT group spent 10 h/night for 21 nights in simulated altitude (3000 m), while the CON group stayed at 1300 m (Takayama, Gifu, Japan) | ↑ (17 d) | ↑ (17 d) | – | ↑ (17 d) | – |
Voss et al. [65] | Runners (n = 10) | The participants spent ~ 6 h·d−1 at 3000–5400 m during waking hours and ~ 10 h·d−1 overnight at 2400–3000 m simulated altitude. Venous blood samples were collected before hypoxic exposure (B0), after + 1 (D1), + 4 (D4), + 7 (D7) and + 14 (D14) d of hypoxic exposure and again + 14 d post-exposure (P14) | ↑ + 0,9 g·dL−1 (D14) | ↑ + 0.4% | ↑ (P14) | – | – |
↓ − 1,3 g·dL−1 (P14) | ↓ (D7) | ||||||
↓ (P14) | |||||||
Intermittent hypoxic exposure (IHE) or training (IHT) | |||||||
Kasperska and Zembron-Lacny [66] | Wrestlers (n = 12) | Twelve wrestlers were assigned to two groups: hypoxia (sports training combined with intermittent hypoxic exposure) and control (sports training only). An approximately 1 h intermittent hypoxic exposure was performed once a day for 10 d with one day off after 6 d | = (NS) | ↑ + 350% (10 d) | – | = (NS) | – |
Abellan, Ventura, Remacha et al. [67] | Triathletes (n = 16) | Sixteen male triathletes were randomly assigned to either the intermittent hypoxia exposure group or the control normoxic group. The exposure group were exposed to simulated altitude (4000–5500 m) in a hypobaric chamber for 3 h d−1, 5 d a week for 4 weeks. Blood and urine samples were collected before and after the first (T0) and the final exposures (T1) and 2 weeks after the final exposure (T2) | = (NS) | = (NS) | – | = (NS) | – |
Sanchez and Borrani [68] | Runners (n = 30) | Fifteen highly trained endurance runners completed a 6-week regimented training with three sessions per week consisting of intermittent runs (6 × work-rest ratio of 5′:5′) on a treadmill at 80–85% of maximal aerobic speed. Nine athletes (the hypoxic group) performed the exercise bouts at FI02 = 10.6–11.4%, while six athletes (the normoxic group) exercised in ambient air | = (NS) | = (NS) | = (NS) | = (NS) | – |